ARB 102A
Alternative Names: ADC-002; ARB-102ALatest Information Update: 22 Oct 2024
At a glance
- Originator Arbele
- Class Antibodies; Antineoplastics; Drug conjugates; Immunoconjugates
- Mechanism of Action Photosensitisers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Gastrointestinal cancer